Literature DB >> 516778

Endocrinology of duodenal ulcer.

W Creutzfeldt, R Arnold.   

Abstract

Several gastrointestinal peptides with proven or suggested endocrine or paracrine functions influence gastric acid secretion, gastrointestinal motility, and mucosal blood flow. Increased or decreased release of such factors could participate in the pathogenesis of duodenal ulcer disease by inducing increased gastric acid concentration in the duodenal bulb. To date, increased stimulation of parietal cells by gastrin has been demonstrated only in patients with gastrinoma, G-cell hyperplasia, gastric outlet obstruction, hyperparathyroidism, excluded antrum, and short bowel syndrome, but not in the usual duodenal ulcer disease. Also, a defective inhibition of parietal cell function by endocrine or paracrine factors, such as gastric inhibitory polypeptide, secretin, somatostatin and vasoactive intestinal polypeptide, seems not to exist in patients with duodenal ulcer disease. However, as long as the physiology of gastrointestinal peptides in gastric secretion and motility is not understood, a possible role of these factors in the pathogenesis of simple duodenal ulcer disease cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 516778     DOI: 10.1007/bf01654769

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  53 in total

1.  The insulinotropic action of gastric inhibitory polypeptide.

Authors:  R A Pederson; H E Schubert; J C Brown
Journal:  Can J Physiol Pharmacol       Date:  1975-04       Impact factor: 2.273

2.  THE ZOLLINGER-ELLISON SYNDROME: RE-APPRAISAL AND EVALUATION OF 260 REGISTERED CASES.

Authors:  E H ELLISON; S D WILSON
Journal:  Ann Surg       Date:  1964-09       Impact factor: 12.969

3.  Calcium challenge in the Zollinger-Ellison syndrome.

Authors:  E Passaro; N Basso; J H Walsh
Journal:  Surgery       Date:  1972-07       Impact factor: 3.982

4.  Hypersecretion of gastrin associated with the short bowel syndrome.

Authors:  E Straus; C D Gerson; R S Yalow
Journal:  Gastroenterology       Date:  1974-02       Impact factor: 22.682

5.  Mucosal gastrin concentration, molecular forms of gastrin, number and ultrastructure of G-cells in patients with duodenal ulcer.

Authors:  W Creutzfeldt; R Arnold; C Creutzfeldt; N S Track
Journal:  Gut       Date:  1976-10       Impact factor: 23.059

6.  [Preoperative examinations in recurrent ulcer in the operated-on stomach].

Authors:  R Arnold; W Creutzfeldt
Journal:  Dtsch Med Wochenschr       Date:  1977-11-18       Impact factor: 0.628

7.  Failure of secretin release in patients with duodenal ulcer.

Authors:  S R Bloom; A S Ward
Journal:  Br Med J       Date:  1975-01-18

8.  Stimulation of gastric inhibitory polypeptide in normal and duodenal ulcer patients.

Authors:  S Cataland; T M O'Dorisio; R Brooks; H S Mekhjian
Journal:  Gastroenterology       Date:  1977-07       Impact factor: 22.682

9.  Gastrin release by bombesin in the dog.

Authors:  G Bertaccini; V Erspamer; P Melchiorri; N Sopranzi
Journal:  Br J Pharmacol       Date:  1974-10       Impact factor: 8.739

10.  Pathomorphologic, biochemical, and diagnostic aspects of gastrinomas (Zollinger-Ellison syndrome).

Authors:  W Creutzfeldt; R Arnold; C Creutzfeldt; N S Track
Journal:  Hum Pathol       Date:  1975-01       Impact factor: 3.466

View more
  2 in total

1.  Antral gastrin-producing G-cells and somatostatin-producing D-cells in different states of gastric acid secretion.

Authors:  R Arnold; M V Hülst; C H Neuhof; H Schwarting; H D Becker; W Creutzfeldt
Journal:  Gut       Date:  1982-04       Impact factor: 23.059

2.  G-cell hyperplasia in chronic hypercalcemia. An immunocytochemical and morphometric analysis.

Authors:  Y Dayal; H J Wolfe
Journal:  Am J Pathol       Date:  1984-09       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.